eNAMPT | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

217 results for “eNAMPT”

Trials

View all 196 →

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression

26 participants · First posted Oct 24, 2019

Active, not recruiting

Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS

15 participants · First posted Jul 10, 2023

Levels of Visfatin/NAMPT in Human Milk

30 participants · First posted Jul 5, 2024

Drugs

View all 11 →

ALT-100

NAMPT PROTAC B4

NAMPT inhibitors (solid tumors)

Organizations

Enact Holdings

United States

News

Aqualung Therapeutics Receives FDA Clearance for Phase 2a Progressive Pulmonary Fibrosis Trial

ARDS Clinical Pipeline Expands with 50+ Companies Developing Novel Therapies

Remedy Plan Therapeutics Achieves Breakthrough with First Safe NAMPT Inhibitor RPT1G for Blood Cancers

Page 1 of 22